Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.5 USD | +5.45% | +3.45% | +38.89% |
07/03 | Earnings Flash (IDXG) INTERPACE BIOSCIENCES Reports Q4 Revenue $10.3M | MT |
07/03 | Interpace Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Interpace Biosciences, Inc.
Upcoming events on Interpace Biosciences, Inc.
Past events on Interpace Biosciences, Inc.
07/03/2024 06:30 pm | Q4 2023 Earnings Release |
14/11/2023 | Annual General Meeting |
09/11/2023 01:59 am | Q3 2023 Earnings Release |
09/08/2023 10:00 pm | Q2 2023 Earnings Release |
28/03/2023 01:35 am | Q4 2022 Earnings Release |
15/11/2022 03:11 am | Q3 2022 Earnings Release |
10/11/2022 | Annual General Meeting |
20/10/2022 | American Thyroid Association Meeting - Poster #119 |
15/08/2022 01:35 pm | Interim 2022 Earnings Release |
17/05/2022 01:45 am | Q1 2022 Earnings Release |
01/04/2022 01:45 am | FY 2021 Earnings Release |
11/11/2021 02:35 am | Q3 2021 Earnings Release |
08/11/2021 | Annual General Meeting |
11/08/2021 01:35 am | Interim 2021 Earnings Release |
12/05/2021 02:17 am | Q1 2021 Earnings Release |
01/04/2021 02:50 am | FY 2020 Earnings Release |
22/01/2021 03:00 am | Q3 2020 Earnings Call |
21/01/2021 07:00 pm | Q3 2020 Earnings Release |
21/10/2020 06:00 pm | Interim 2020 Earnings Call |
20/10/2020 05:30 pm | Interim 2020 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 24,1 30,8 -21.8% | 32,4 32,3 0.45% | 41,3 42,0 -1.54% |
EBITDA Million USD | Released Forecast Spread | -17,0 -11,8 -43.72% | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -26,4 -18,9 -40.14% | -26,1 -23,5 -11.02% | -14,0 -12,7 -10.07% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -26,7 -19,6 -35.83% | -26,1 -23,4 -11.65% | -15,4 -13,9 -11.26% |
Net income Million USD | Released Forecast Spread | -26,7 -19,8 -35.31% | -29,5 -26,7 -10.46% | -14,9 -13,3 -11.98% |
EPS USD | Released Forecast Spread | -7,25 -4,41 -64.59% | -7,32 -6,62 -10.57% | -3,61 -2,61 -38.31% |
Announcement Date | 22/04/20 | 31/03/21 | 31/03/22 |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 10,9 11,5 -5.63% | 10,4 9,00 15.3% | 9,35 10,5 -10.94% | 8,19 12,5 -34.49% |
EBIT Million USD | Released Forecast Spread | -3,28 -2,00 -64.21% | -2,03 -3,25 37.35% | -3,73 -2,09 -78.99% | -0,78 -0,93 15.68% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,69 -2,13 -73.24% | -2,18 -3,38 35.65% | -3,87 -2,22 -74.37% | -1,27 -1,06 -19.34% |
Net income Million USD | Released Forecast Spread | -3,73 -2,13 -75.07% | -2,25 -3,38 33.52% | -3,94 -2,22 -77.43% | -14,2 -1,06 -1240.38% |
EPS USD | Released Forecast Spread | -0,89 -0,26 -242.31% | -0,53 -0,80 33.75% | -0,93 -0,52 -78.85% | -3,35 -0,25 -1240% |
Announcement Date | 31/03/22 | 16/05/22 | 15/08/22 | 14/11/22 |
Past sector events for Interpace Biosciences, Inc.
29/03/2024 02:30 am | HAPVIDA PARTICIPAÇÕES E INVESTIMENTOS S.A.: Q4 2023 Earnings Release |
28/02/2024 | ODONTOPREV S.A.: Q4 2023 Earnings Release |
09/11/2023 04:24 am | HAPVIDA PARTICIPAÇÕES E INVESTIMENTOS S.A.: Q3 2023 Earnings Release |
08/11/2023 | ODONTOPREV S.A.: Q3 2023 Earnings Release |
10/08/2023 02:30 am | HAPVIDA PARTICIPAÇÕES E INVESTIMENTOS S.A.: Q2 2023 Earnings Release |
09/08/2023 | ODONTOPREV S.A.: Q2 2023 Earnings Release |
16/05/2023 06:53 am | HAPVIDA PARTICIPAÇÕES E INVESTIMENTOS S.A.: Q1 2023 Earnings Release |
10/05/2023 | ODONTOPREV S.A.: Q1 2023 Earnings Release |
01/03/2023 | ODONTOPREV S.A.: Q4 2022 Earnings Release |
28/02/2023 | HAPVIDA PARTICIPAÇÕES E INVESTIMENTOS S.A.: Q4 2022 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IDXG Stock
- Calendar Interpace Biosciences, Inc.